Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston
Pfizer at Discovery on Target 2026
Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website
Pfizer brings 10 presentations to Discovery on Target 2026 in Boston. Its program centres on hard drug targets, especially orphan GPCRs, and on finding hits with DNA-encoded libraries. It also covers brain-penetrant inverse agonists for GPR61, a small-molecule GIPR antagonist for obesity and immune responses to antibody-drug conjugates.
| Organization | Discovery on Target 2026 Attendance |
|---|---|
Pfizer New York, NY | |
Global pharmaceutical company developing medicines and vaccines in oncology, inflammation and immunology, internal medicine and rare diseases. | Chair Tue Sep 29 1:45pm–1:50pm Talk Tue Sep 29 2:20pm–2:50pm Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Panel Wed Sep 30 7:30am–8:15am Talk Wed Sep 30 11:50am–12:20pm Chair Wed Sep 30 2:00pm–2:05pm Talk Wed Sep 30 2:35pm–3:05pm Panel Thu Oct 1 7:30am–8:15am Talk Thu Oct 1 9:35am–10:05am Talk Thu Oct 1 3:30pm–4:00pm |
Instantly find 20 buyers from Pfizer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction